PEOPLE - InnerPulse makes appointment:
This article was originally published in Clinica
Executive Summary
InnerPulse (Research Triangle Park, North Carolina), a firm that is developing an implantable defibrillator, has appointed Elsa Abruzzo as vice-president of regulatory and quality affairs. She joins from AtriCure, where she served as vice-president of regulatory and clinical affairs. The position is newly-created as the firm moves towards clinical studies and regulatory approval of its device. Ms Abruzzo has served for more than 18 years in the device industry, including terms at CryoLife and J&J's Cordis.
You may also be interested in...
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.
Generic Or Innovator? Sandoz Sues CMS Over Potential Change In Rebate Classification
Sandoz argued against paying higher rebates for two of its drugs via the Centers for Medicare and Medicaid Services’ Medicaid drug rebate program in a US court six years after the suggestion was first made.